American Century Companies’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-329,774
Closed -$3.53M 2340
2021
Q3
$3.53M Buy
329,774
+111
+0% +$1.19K ﹤0.01% 1115
2021
Q2
$5.12M Buy
329,663
+14,670
+5% +$228K ﹤0.01% 982
2021
Q1
$5.11M Sell
314,993
-14,256
-4% -$231K ﹤0.01% 932
2020
Q4
$6.97M Sell
329,249
-10,136
-3% -$215K 0.01% 826
2020
Q3
$5.03M Sell
339,385
-36,182
-10% -$536K ﹤0.01% 804
2020
Q2
$5.53M Buy
375,567
+113,223
+43% +$1.67M 0.01% 765
2020
Q1
$3.08M Buy
262,344
+9,950
+4% +$117K ﹤0.01% 791
2019
Q4
$5.93M Buy
252,394
+88,339
+54% +$2.08M 0.01% 783
2019
Q3
$3.04M Buy
164,055
+10,118
+7% +$187K ﹤0.01% 898
2019
Q2
$2.86M Buy
153,937
+23,112
+18% +$430K ﹤0.01% 961
2019
Q1
$3.2M Sell
130,825
-3,701
-3% -$90.4K ﹤0.01% 918
2018
Q4
$3.49M Buy
134,526
+2,278
+2% +$59.1K ﹤0.01% 881
2018
Q3
$4.19M Buy
132,248
+4,296
+3% +$136K ﹤0.01% 899
2018
Q2
$4.97M Buy
+127,952
New +$4.97M 0.01% 850
2016
Q3
Sell
-33,598
Closed -$606K 1370
2016
Q2
$606K Sell
33,598
-7,811
-19% -$141K ﹤0.01% 1218
2016
Q1
$786K Buy
+41,409
New +$786K ﹤0.01% 1151